Ramucirumab as Second-Line Therapy in Metastatic Gastric Cancer: Real-World Data from the RAMoss Study

Di Bartolomeo M;Niger M;Tirino G;Petrillo A;Berenato R;Laterza MM;Pietrantonio F;Morano F;Antista M;Lonardi S;Fornaro L;Tamberi S;Giommoni E;Zaniboni A;Rimassa L;Tomasello G;Sava T;Spada M;Latiano T;Bittoni A;Bertolini A;Proserpio I;Bencardino KB;Graziano F;Beretta G;Galdy S;Ventriglia J;Scagnoli S;Spallanzani A;Longarini R;De Vita F

2018-01-01